Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0090
+0.0010 (12.50%)
Mar 25, 2026, 9:30 AM EST
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $1.13 million as of March 26, 2026. Its market cap has increased by 27.41% in one year.
Market Cap
1.13M
Enterprise Value
60.44M
Revenue
20.18M
Ranking
n/a
PE Ratio
23.88
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 1.13M, a decrease of -99.48%. That is a compound annual growth rate of -47.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 1.13M | -6.40% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 1.49M |
| Enzolytics | 1.45M |
| Carisma Therapeutics | 1.39M |
| Protagenic Therapeutics | 1.27M |
| CERo Therapeutics Holdings | 1.14M |
| Halberd | 1.12M |
| International Stem Cell | 1.08M |
| Eastgate Biotech | 1.06M |